Skip to main content

and
  1. Article

    Open Access

    Medication-taking behaviour in Bulgarian women with postmenopausal osteoporosis treated with denosumab or monthly oral bisphosphonates

    Persistence with osteoporosis therapy is critical for fracture risk reduction. This observational study evaluated medication-taking behaviour of women with postmenopausal osteoporosis receiving denosumab or or...

    T. Petranova, M. Boyanov, A. Shinkov, R. Petkova, M. Intorcia in Archives of Osteoporosis (2017)

  2. Article

    Open Access

    GRAND-4: the German retrospective analysis of long-term persistence in women with osteoporosis treated with bisphosphonates or denosumab

    This retrospective database study assessed 2-year persistence with bisphosphonates or denosumab in a large German cohort of women with a first-time prescription for osteoporosis treatment. Compared with intrav...

    P. Hadji, I. Kyvernitakis, P. H. Kann, C. Niedhart in Osteoporosis International (2016)

  3. Article

    Open Access

    Persistence with denosumab and persistence with oral bisphosphonates for the treatment of postmenopausal osteoporosis: a retrospective, observational study, and a meta-analysis

    The objectives of this study were to estimate persistence with denosumab and put these results in context by conducting a review of persistence with oral bisphosphonates. Persistence with denosumab was found t...

    L. Karlsson, J. Lundkvist, E. Psachoulia, M. Intorcia in Osteoporosis International (2015)